Forte Biosciences Share Price
Stocks
FBRX
US34962G2084
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 27/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
+0.09% | +182.32% |
| 27/08 | Argenx SE completed the acquisition of Forte Biosciences, Inc.. | CI |
| 27/08 | Argenx Completes Acquisition of Forte Biosciences | MT |
| Market Cap | 193.91Cr 167.09Cr 156.66Cr 143.01Cr 269.41Cr 19TCr 270.27Cr 1.86TCr 725.19Cr 9.36TCr 728.02Cr 712.18Cr 31TCr | P/E 2026 * |
-17.2x | P/E 2027 * | -18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 193.91Cr 167.09Cr 156.66Cr 143.01Cr 269.41Cr 19TCr 270.27Cr 1.86TCr 725.19Cr 9.36TCr 728.02Cr 712.18Cr 31TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
97.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Forte Biosciences
| 1 day | +0.03% | ||
| 1 week | +0.09% | ||
| Current month | +0.51% | ||
| 1 month | +0.60% | ||
| 3 months | +303.72% | ||
| 6 months | +154.77% | ||
| Current year | +182.32% |
| 1 week | 76.92 |  | 77 |
| 1 month | 76.51 | | 77 |
| Current year | 15.51 | | 77.2 |
| 1 year | 10.11 | | 77.2 |
| 3 years | 4.11 | | 77.2 |
| 5 years | 4.11 | | 786.75 |
| 10 years | 4.11 | | 1,349.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Wagner
CEO | Chief Executive Officer | 55 | 01/01/2018 |
Anthony Riley
DFI | Director of Finance/CFO | 59 | 01/03/2020 |
| Chief Operating Officer | - | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Wagner
CHM | Chairman | 55 | - |
Steven Kornfeld
BRD | Director/Board Member | 58 | 01/06/2020 |
Barbara Finck
BRD | Director/Board Member | 79 | 16/03/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/08/26 | Issuer sale | Director | -51,353 | 0.2508% | ||
| 27/08/26 | Issuer sale | Director | -54,353 | 0.2654% | ||
| 27/08/26 | Issuer sale | Director | -55,353 | 0.2703% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +0.09% | +599.91% | +266.75% | 193.91Cr | |
| -1.59% | -3.35% | +52.37% | +93.70% | 6.95TCr | |
| -1.34% | -0.75% | +48.21% | +91.86% | 6.5TCr | |
| +0.30% | -0.69% | +52.56% | +10.23% | 2.65TCr | |
| -2.35% | -5.75% | -12.90% | +448.54% | 2.59TCr | |
| -8.37% | -12.43% | +2.08% | -16.71% | 2.56TCr | |
| -0.96% | +10.36% | +283.06% | +436.50% | 2.02TCr | |
| -0.51% | +0.23% | +35.77% | -18.70% | 2TCr | |
| -1.91% | -4.37% | +13.28% | +535.19% | 1.57TCr | |
| -1.47% | +0.68% | +45.51% | +143.08% | 1.35TCr | |
| Average | -1.82% | -1.72% | +111.98% | +199.04% | 2.84TCr | |
| Weighted average by Cap. | -1.92% | -1.49% | +57.46% | +152.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.11Cr -7.85Cr -7.36Cr -6.72Cr -13Cr -870.78Cr -13Cr -87Cr -34Cr -439.57Cr -34Cr -33Cr -1.46TCr | -11Cr -9.25Cr -8.68Cr -7.92Cr -15Cr -1.03TCr -15Cr -102.95Cr -40Cr -518.17Cr -40Cr -39Cr -1.72TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | $76.99 | +0.03% | 14,00,110 |
| 25/26/25 | $76.97 | +0.03% | 12,35,752 |
| 24/26/24 | $76.95 | +0.04% | 12,55,679 |
| 21/26/21 | $76.92 | +0.04% | 20,12,128 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBRX Stock
Select your edition
All financial news and data tailored to specific country editions
